There has been a flurry of media coverage about over-the-counter (OTC) drug switches lately, spurred by the news that Pfizer had acquired the future marketing rights for OTC Nexium, one of the top-selling prescription drugs that loses patent exclusivity in 2014.
Stay tuned for more news like this as other blockbuster prescription drugs go off patent and pharmaceutical companies seek ways to extend their lifecycle. The future of medicine will undoubtedly involve the broader availability of drugs that ...